why choose us

First received: September 26, 2024

Clinical Trial: AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Systemic Lupus Erythematosus (SLE)

Study Type: OBSERVATIONAL


Official Title: AZAHAR Study. Observational Retrospective Study To Describe Characteristics And Clinical Outcomes of Patients With Systemic Lupus Erythematosus Initiating Saphnelo (Anifrolumab) in a Real-World Settin

Brief Summary: AZAHAR is an observational retrospective and longitudinal study with adults patients with SLE who initiated treatment with anifrolumab from June 1, 2023 to May 31, 2024.The overall objective is to describe the characteristics and clinical outcomes of patients with SLE that initiated anifrolumab during its first year of commercialization in Spain.

Read more